Richard L. Wynn, PhD, is professor emeritus of pharmacology in the Department of Neural and Pain Sciences at the University of Maryland School of Dentistry.

He is a nationally recognized speaker, author, columnist, and consultant on dental drug therapeutics and drug information for the dental professional. He is the lead author of the most recognized chairside dental drug reference book, Drug Information Handbook for Dentistry, now in its 29th edition.

Dr. Wynn keeps the dental profession informed about current issues relative to drugs in dentistry, including new therapeutic agents, new drug interactions, and newly reported adverse reactions in dental patients. He researches the literature daily for new reports of interest to the profession.  

This foundational course explores the definitions and pharmacology of oral sedation. Designed for dental professionals seeking to understand and implement oral sedation, this course provides a comprehensive review of the drugs and requirements necessary to achieve Oral Sedation Permit Level One status, as outlined by the Maryland State Board of Dental Examiners. The course is divided into two parts, each focusing on different aspects of oral sedation.

Upon completion of Program One, Part 1, participants will be able to:

• Define anxiolysis.
• Define moderate enteral sedation.
• Explain the criteria for obtaining a Class I permit.
• Identify the conditions evaluated for the Class I Permit test.
• Distinguish between minimal and moderate sedation.
• Describe the effects of diazepam in achieving minimal sedation.
• Describe the effects of diazepam in achieving moderate sedation.
• Explain the use of triazolam for minimal sedation.
• Explain the use of triazolam for moderate sedation.
• List the risks associated with stress.